Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years

June 25, 2016 | Author: sstrumello7395 | Category: N/A

Embed

Donate

Report this link

Description

Authors: Herold KC, Gitelman S, Greenbaum C, Puck J, Hagopian W, Gottlieb P, Sayre P, Bianchine P, Wong E, Seyfert-Margo...

Comments

SUPPORT DOCURI

We need your help!

Thank you for interesting in our services. We are a non-profit group that run this website to share documents. We need your help to maintenance this website.

Donate
Sharing

To keep our site running, we need your help to cover our server cost (about $400/m), a small donation will help us a lot.

No, thanks! Close the box.